Improving Outcomes for Esophageal Cancer using Proton Beam Therapy

Michael D. Chuong(Baptist Hospital of Miami), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Christopher L. Hallemeier(Mayo Clinic in Arizona), Shahed N. Badiyan(University of Maryland, Baltimore), Salma K. Jabbour(Rutgers, The State University of New Jersey), Vivek Verma(Christ University), Kenneth W. Merrell(Mayo Clinic), Heng Li(The University of Texas MD Anderson Cancer Center), Jen Yu(University of Maryland, Baltimore), Mark V. Mishra(University of Maryland, Baltimore)
International Journal of Radiation Oncology*Biology*Physics
December 15, 2015
10.1016/j.ijrobp.2015.11.043
Cited by 71

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Integrating genomic features for non-invasive early lung cancer detection
|Nature|2020|689
Neuropeptide S
|Neuron|2004|516
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
|Nature Cancer|2020|369